New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2014
10:54 EDTFURX, CLD, ETRM, AVGO, FIVE, UNXL, CBG, PL, LINTA, RDNTHigh option volume stocks
Check below for free stories on FURX;LINTA;PL;CBG;UNXL;FIVE;AVGO;ETRM;CLD;RDNT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 28, 2014
16:05 EDTAVGOAvago sees Q4 revenue up 18%-22%, consensus $1.42B
Subscribe for More Information
16:04 EDTAVGOAvago reports Q3 EPS $1.26, consensus $1.06
Subscribe for More Information
15:22 EDTAVGONotable companies reporting after market close
Subscribe for More Information
11:41 EDTAVGOAvago technical comments before earnings
The shares have outperformed most indexes in the last three months, trading up over 8%. Price is also very close to the 52-week high and life high at $77.21. On stronger than expected positive news and guidance, the life high would be an easy reach from current levels. Without overhead resistance, a next likely upside target would be at the $80 to $85 area depending on the degree of surprise. If the news is not as bullish as sentiment in the name supposes, there is greater risk of a strong downside risk given the big advance the stock has made. In the year-to-date period price is up over 44.6%. On an increasing scale of disappointment, the following support levels could be tested as downside objectives: $73.15, $69.38, and $67.52. The $70 area has been strong support in the last several months as shares consolidated gains. A breakdown below that level could therefore precipitate further price weakness.
08:55 EDTETRMOn The Fly: Pre-market Movers
HIGHER: Digital Ally (DGLY), up 16% after announcing order from Michigan State Police for over $1.1M... EnteroMedics (ETRM), up 12.4% after reporting three-year data from Maestro RC system... Repros (RPRX), up 0.8% after Androxal achieves superiority in both co-primary endpoints in a study... Synthetic Biologics (SYN), up 2.7% after Pfizer (PFE) was granted FDA Fast Track designation for its investigational Clostridium difficile vaccine candidate. Synthetic Biologics announced earlier this week that SYN-004, the company's lead anti-infective product candidate for the prevention of the effects of C. difficile, will be presented in October... Signet (SIG), up 3.9% after Q2 revenue tops consensus. DOWN AFTER EARNINGS: Abercrombie & Fitch (ANF), down 5.7%... Guess (GES), down 8.3%... Frontline (FRO), down 7%. ALSO LOWER: Williams-Sonoma (WSM), down 10.9% after downgraded at Morgan Stanley following the company's Q2 earnings report... GT Advanced (GTAT), down 2% after downgraded at Raymond James... Sungy Mobile (GOMO), down 20.1% following earnings report, CFO resignation, downgrade of stock at Oppenheimer... Genesco (GCO), down 7.7% after cutting fiscal year forecast.
07:09 EDTETRMEnteroMedics reports three-year data from Maestro RC system
EnteroMedics announced that three year diabetes, hypertension and weight loss data from the company's DM2 ENABLE Study of VBLOC vagal blocking therapy delivered via the Maestro Rechargeable System continue to demonstrate both medically meaningful weight loss as well as improvement in diabetes control in obese subjects with Type II Diabetes Mellitus. The DM2 Study is designed to evaluate the safety and efficacy of VBLOC vagal blocking therapy delivered via the Maestro RC System in 28 diabetic subjects with obesity by measuring average percentage excess weight loss, blood sugar, fasting plasma glucose and blood pressure, following device activation. To date, no unanticipated adverse device effects have been reported and the safety profile is similar to that seen in other VBLOC clinical trials. These metabolic effects in diabetes, hypertension and weight loss are consistent with previous findings from other time points and are considered medically meaningful improvements.
August 27, 2014
18:05 EDTLINTALiberty Interactive completes Liberty TripAdvisor Holdings spin-off
Subscribe for More Information
07:34 EDTAVGOAvago Q3 results likely to beat expectations, says Oppenheimer
Subscribe for More Information
August 25, 2014
16:33 EDTLINTALiberty sites when-issued trading for spin-off of Liberty TripAdvisor Holdings
Liberty Interactive (LINTA, LVNTA) announced that, in connection with its upcoming spin-off of its subsidiary Liberty TripAdvisor Holdings, it has been advised by Nasdaq that shares of TripAdvisor Holdings Series A and Series B common stock will trade on a when-issued basis on the Nasdaq Global Select Market under the symbols “LTPAV” and “LTPBV”, respectively, on August 27. The Spin-off will be effected through the distribution, by means of a dividend, of TripAdvisor Holdings common stock at 5:00 p.m., New York City time, on August 27 to holders of Liberty Ventures common stock. The record date for the dividend was 5:00 p.m., New York City time, on August 21. Liberty expects that the TripAdvisor Holdings Series A and Series B common stock will begin trading in the regular way on the Nasdaq Global Select Market under the symbols “LTRPA” and “LTRPB” beginning on August 28. The completion of the Spin-off remains subject to the satisfaction or waiver, as applicable, of a number of conditions.
09:19 EDTLINTATripAdvisor price target raised to $100 from $88 at Wunderlich
Subscribe for More Information
August 22, 2014
11:17 EDTAVGOPeregrine unlikely to receive competing bid, says Oppenheimer
Oppenheimer believes Peregrine (PSMI) is unlikely to receive a competing takeover bid to Murata's since Murata is Peregrine's largest customer and Avago (AVGO) and Skyworks (SWKS) are looking to diversify away from mobile. Opco thinks Murata may look to divest Peregrine's non-mobile business, and views Skyworks, RF Micro Devices (RFMD), Analog Devices (ADI), and M/A-Com Technology (MTSI) as logical buyers for the business.
August 21, 2014
17:00 EDTAVGOAvago files to sell $1B of 2% convertible senior notes due 2021
Subscribe for More Information
10:13 EDTFIVEStocks with call strike movement; PBR FIVE
Subscribe for More Information
09:00 EDTAVGOSeveral semi companies have positive read through from deal, says Sterne Agee
After Infineon (IFNNY) bought International Rectifier (IRF), Sterne Agee thinks the deal indicates that the shares ofother players in the sector - including Spansion (CODE), NXP Semiconductors (NXPI), and Avago (AVGO) - can rise further. The firm keeps Buy ratings on the latter three stocks.
August 20, 2014
09:17 EDTCLDCloud Peak announces termination of TRA with Rio Tinto
Subscribe for More Information
August 19, 2014
06:29 EDTAVGOMorgan Stanley remains a buyer of Avago
Subscribe for More Information
August 18, 2014
10:29 EDTAVGOGoldman cuts sector view on semiconductors to Cautious
Subscribe for More Information
08:04 EDTAVGOSemiconductors sector downgraded to Cautious from Neutral at Goldman
Goldman downgraded the Semiconductors sector to Cautious given signs the cycle is turning based on expectations for a slowdown in semiconductor revenue growth, above trend semi unit shipments that should normalize, and stretching lead times. As a result, the analyst sees risk to Q4 estimates and sees further downside of 10%-25% for the SOX (SOX) and downgraded NXP Semiconductors (NXPI) to Sell from Neutral, InvenSense (INVN) to Neutral from Buy, and removed Maxim Integrated (MXIM) from the Conviction Buy List.
06:13 EDTLINTALiberty Interactive added to Focus List at Citigroup
Subscribe for More Information
06:10 EDTLINTALiberty Ventures downgraded to Sell from Neutral at Citigroup
Citigroup downgraded Liberty Ventures (LVNTA) to Sell on its belief the company will not receive the $350M in cash from the Trip spin and risk it acquires LDC from Liberty Interactive (LINTA). Citi raised its price target for shares to $70 from $69.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use